VRTX

Q: What is the price of Vertex Pharmaceuticals (VRTX) today?

The current price of Vertex Pharmaceuticals (VRTX) is $ 442.36, representing a -6.97% gain over the past year. The stock began the year trading around $ 453.36 and is currently priced at $ 442.36. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Vertex Pharmaceuticals (VRTX) pay dividends?

Vertex Pharmaceuticals (VRTX) did not pay dividends over the past year.

Vertex Pharmaceuticals Incorporated

Price

$ 442.36

return (12m)

-6.97%

p/e

28.19

p/bv

5.97

DIVIDEND YIELD

0.00%

VRTX price

VRTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment VRTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.16%

3 months

-4.64%

1 year

-6.97%

2 years

11.26%

5 years

107.10%

10 years

419.32%

Fundamentals VRTX

review the fundamentals of Vertex Pharmaceuticals shares

P/E

28.19

Sector: -3.90 Industry: -3.90

P/S (PSR)

9.29

Sector: -3.94 Industry: -3.94

P/BV

5.97

Sector: 1.83 Industry: 1.83

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

15.42%

Sector: -61.11% Industry: -61.11%

ROE

21.18%

Sector: -61.17% Industry: -61.17%

ROIC

29.81%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

32.94%

Sector: -39.18% Industry: -39.18%

GROSS MARGIN

86.24%

Sector: 38.38% Industry: 38.38%

OPERATING MARGIN

39.06%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

23.42

Sector: -3.73 Industry: -3.73

EV/EBIT

23.93

Sector: -3.95 Industry: -3.95

PRICE-TO-ASSETS

4.35

Sector: 1.35 Industry: 1.35

BVPS

73.49

Sector: 1.90 Industry: 1.90

EPS

15.56

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.73

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.27

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

9.64%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

11.04%

Sector: - Industry: -

FAIR VALUE OF Vertex Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 442.36

Fair Value

$ 0.00

Upside/Downside Return potential.

-63.74%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals VRTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

VRTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

Average Investor10 user rating

5.0 (19 people)

United States

37 years

Founded: 1989

1991

Time since IPO - 35 years

3.400

Employees

Vertex Pharmaceuticals Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $111.43 Billions, with shareholders equity totaling $18.67 Billions.

The company employs approximately 3.400 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Vertex Pharmaceuticals Incorporated reported $12.00 Billions in revenue, generating net income of $3.95 Billions.

Key financial metrics include a P/E ratio of 28.19, a price-to-book (P/B) ratio of 5.97, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VRTX.

Market cap

$ 111.43 Billions

Net worth

$ 18.67 Billions

$ 18,665,800,000.00

Assets

$ 25.64 Billions

$ 25,643,000,000.00

Total Shares Outstanding

254.00 Millions

254,000,000

Average Daily Trading Volume

$ 1.48 Million

$ 1,484,468.36

Sector

Health Care

Industry

Biotechnology

VRTX

revenue by Business Segment Vertex Pharmaceuticals

Revenue by Region Vertex Pharmaceuticals

VRTX revenue and profits

Financial Results VRTX

DRAG THE FRAME TO SEE MORE DATA

VRTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 876.58 27,66% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 216.80 66,99% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.50 64,95% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 27.41 34,18% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 212.90 26,65% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 122.97 60,95% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 206.17 54,28% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 876.58 27,66% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 216.80 66,99% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.50 64,95% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 27.41 34,18% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 212.90 26,65% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 122.97 60,95% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 206.17 54,28% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Vertex Pharmaceuticals (VRTX) today?

The current price of Vertex Pharmaceuticals (VRTX) is $ 442.36, representing a -6.97% gain over the past year. The stock began the year trading around $ 453.36 and is currently priced at $ 442.36. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Vertex Pharmaceuticals (VRTX) pay dividends?

Vertex Pharmaceuticals (VRTX) did not pay dividends over the past year.

Is Vertex Pharmaceuticals (VRTX) a good investment?

Vertex Pharmaceuticals (VRTX) is currently trading at $ 442.36 with a P/E ratio of 28.19%. This represents a -2,796% premium compared to its historical average P/E. Over the past year, the stock has gained -6.97 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -6.97%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vertex Pharmaceuticals (VRTX) stock?

You can buy Vertex Pharmaceuticals (VRTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol VRTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Vertex Pharmaceuticals (VRTX) yield today?

Over the past month, Vertex Pharmaceuticals (VRTX) has returned -10.16% — -6.97% over the past year, and 107.10% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Vertex Pharmaceuticals (VRTX) today at the current price of $ 442.36 your total investment would be $ 44,235.50.

Based on historical performance, the investment would have grown to approximately:

$ 41,152.29 after 1 year
$ 91,611.72 after 5 years
$ 229,723.80 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VRTX

Vertex Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VRTX

review the fundamentals of Vertex Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

United States

37 years

1991

3.400

PROFIT X PRICE VRTX

Financial Results VRTX

VRTX cash flow

Asset, Revenue and Profit Growth - VRTX

VRTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions